RespireRx Pharmaceuticals Inc (RSPI): Dew, Man isn't that the truth. If Bian...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33392
Boards Moderated	87
Alias Born	03/22/2005

gfp927z

Re: DewDiligence post# 11600

Thursday, 10/18/2007 2:25:48 AM

Thursday, October 18, 2007 2:25:48 AM

Dew, Man isn't that the truth. If Bianco had only dropped Xyotax completely and concentrated on Pixantrone, but nooo... They always choose to whip the dead horse, and run the company into the ground.

A similar phenomenon occurs in research labs. Dependent on grants, they'll do whatever it takes to continue getting funded. The amyloid vrs tau wars were an example, where for years labs could only get funding if they stayed within the amyloid orthodoxy.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM